Efficacy and Safety of an Aflibercept Treat-and-Extend Regimen in Treatment-Naïve Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial

Efficacy and Safety of an Aflibercept Treat-and-Extend Regimen in Treatment-Naïve Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial

Objectives. To evaluate efficacy and safety of an aflibercept treat-and-extend (TAE) regimen in patients with macular oedema (MO) secondary to central retinal vein occlusion (CRVO). Design, Setting, and Patients. Phase IV, prospective, open-label, single-arm trial in 11 Spanish hospitals. Treatment-...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of ophthalmology 2018-01, Vol.2018 (2018), p.1-7
Hauptverfasser: Manzanas, Lucía, Crespí, Jaume, Gallego, Roberto, Donate, Juan, Araiz, Javier, Arias, L., Fonollosa, Alex, Cervera, Enrique, Navea-Tejerina, Amparo, Gómez-Ulla, Francisco, García-Arumí, José, Suarez-De-Figueroa, Marta
Format: Artikel
Sprache:eng
Schlagworte:
Clinical Study
Diabetes
Diabetic retinopathy
Disease
Dropsy
Drug dosages
Edema
FDA approval
Ischemia
Lasers
Patients
Pharmaceutical industry
Standard deviation
Surgery
Vascular endothelial growth factor
Veins & arteries
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives. To evaluate efficacy and safety of an aflibercept treat-and-extend (TAE) regimen in patients with macular oedema (MO) secondary to central retinal vein occlusion (CRVO). Design, Setting, and Patients. Phase IV, prospective, open-label, single-arm trial in 11 Spanish hospitals. Treatment-naïve patients with
ISSN:2090-004X
2090-0058
DOI:10.1155/2018/8310350